(NasdaqGM:IOVA), SAN CARLOS, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that Dan Kirby will join the Company's executive leadership team in the newly created role of Chief […]

LAS VEGAS, Feb. 10, 2025 (GLOBE NEWSWIRE) — Pando, the leading Logistics AI company, today announced the launch of its AI Teams for Logistics, a groundbreaking suite of AI Agents designed to automate freight procurement, dispatch planning, and freight audit and payment processes for global brands. Purpose-built to transform logistics operations, its new 'Logistics Services

(NasdaqGM:ATLN), ENGLEWOOD CLIFFS, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) — Atlantic International Corp. (“Atlantic”) (Nasdaq: ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions (“Lyneer”) has entered into a strategic workforce agreement with a major North American distributor serving the aerospace, defense, automotive, and

(NASDAQ:INMB), The Company reports results of a double-blinded, randomized, placebo-controlled study, known as “MissionEB,” investigating CORDStrom for treatment of RDEB in pediatric patients, which evidence a favorable benefit-risk profile in support of the intended applications for marketing authorization. CORDStrom, developed by INmune Bio is a patent pending, off the shelf, advanced mesenchymal stromal cell (MSC)

(NASDAQ:TLRY),(TSX:TLRY), NEW YORK and LEAMINGTON, Ontario, Feb. 10, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced the completion of Phase I of its accelerated growth plan for its cannabis supply

(NASDAQ:HYFM), SHOEMAKERSVILLE, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) (“Hydrofarm” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, par value $0.0001, which will be effective at 5:00 pm Eastern Time on February 12, 2025. The Company's

(NasdaqGM:IVVD), WALTHAM, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. The presentation is set to take place at 1:20 PM ET on Wednesday, February 12th. The live webcast

(NASDAQ:HAIN), Strong Operating Cash Flow and Reduction in Debt; Positioned to Pivot to Growth in Back HalfExploring Strategic Options for Personal Care Category HOBOKEN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) — Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported

(TSX-V:CRI), TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company“) (TSXV: CRI) is pleased to provide an update on its 2024 fieldwork results at the Florence Lake nickel project located in Labrador. Highlights include: Seahorse Lake Intrusive CRI 2024 sampling confirms Ni-Co potential and ~7.5km strike length to the variably

Victoria (BC), London & New York, Feb. 10, 2025 (GLOBE NEWSWIRE) — British Columbia Investment Management Corporation (“BCI”), one of Canada's largest institutional investors, today announced it has completed the sale of its majority stake in Hayfin Capital Management (“Hayfin”) to Arctos Partners (“Arctos”), a private investment firm. BCI remains a significant and strategic limited